Transcriptional gene expression profiling of small cell lung cancer cells

Cancer Research

Volumn 63, Issue 8, 2003, Pages 1943-1953

  Pedersen, Nina ^a   Mortensen, Shila ^a   Sørensen, Susanne B ^a   Pedersen, Mikkel W ^a   Rieneck, Klaus ^b   Bovin, Lone F ^b   Poulsen, Hans Skovgaard ^a  

^a FINSEN LABORATORY   (Denmark)

^b International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID TRANSPORTER; BETA GALACTOSIDASE; BETA TUBULIN; CALMODULIN; CELL ADHESION MOLECULE; CELL NUCLEUS RECEPTOR; CHROMOGRANIN; CHROMOGRANIN B; DIHYDROPYRIMIDINASE; ENOLASE; GASTRIN RELEASING PEPTIDE; GROWTH FACTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; HISTONE; HOMEODOMAIN PROTEIN; IMMUNOGLOBULIN; KINESIN; MEMBRANE PROTEIN; METHYLTRANSFERASE; NERVE CELL ADHESION MOLECULE; NEURITE PROMOTING FACTOR; ONCOPROTEIN; PROTEINASE; SEMAPHORIN; SYNAPTOJANIN; THYROID TRANSCRIPTION FACTOR 1; TRANSCRIPTION FACTOR; TRYPTOPHAN HYDROXYLASE; VASCULOTROPIN; ZINC FINGER PROTEIN;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL DIVISION; CELL PROLIFERATION; CLUSTER ANALYSIS; CONTROLLED STUDY; DNA MICROARRAY; FETUS; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG SMALL CELL CANCER; MALE; NEUROENDOCRINE SYSTEM; NORMAL HUMAN; ONCOGENE; PRIORITY JOURNAL; XENOGRAFT;

ADULT; ANIMALS; BRAIN; CARCINOMA, SMALL CELL; CELL DIVISION; CLUSTER ANALYSIS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEUROSECRETORY SYSTEMS; TRANSCRIPTION, GENETIC; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0037447191     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (74)

1. Bhattacharjee, A., Richards, W. G., Staunton, J., Li, C., Monti, S., Vasa, P., Ladd, C., Beheshti, J., Bueno, R., Gillette, M., Loda, M., Weber, G., Mark, E. J., Lander, E. S., Wong, W., Johnson, B. E., Golub, T. R., Sugarbaker, D. J., and Meyerson, M. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc. Natl. Acad. Sci. USA, 98: 13790-13795, 2001.
2. Garber, M. E., Troyanskaya, O. G., Schluens, K., Petersen, S., Thaesler, Z., Pacyna-Gengelbach, M., van de, R. M., Rosen, G. D., Perou, C. M., Whyte, R. I., Altman, R. B., Brown, P. O., Botstein, D., and Petersen, I. Diversity of gene expression in adenocarcinoma of the lung. Proc. Natl. Acad. Sci. USA, 98: 13784-13789, 2001.
3. Beer, D. G., Kardia, S. L., Huang, C. C., Giordano, T. J., Levin, A. M., Misek, D. E., Lin, L., Chen, G., Gharib, T. G., Thomas, D. G., Lizyness, M. L., Kuick, R., Hayasaka, S., Taylor, J. M., Iannettoni, M. D., Orringer, M. B., and Hanash, S. Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat. Med., 8: 816-824, 2002.
4. Engelholm, S. A., Spang-Thomsen, M., Vindelov, L. L., Brunner, N., Nielsen, M. H., Hirsch, F., Nielsen, A., and Hansen, H. H. Comparison of characteristics of human small cell carcinoma of the lung in patients, in vitro and transplanted into nude mice. Acta Pathol. Microbiol. Immunol. Scand., 94: 325-336, 1986.
5. De Leij, L., Postmus, P. E., Buys, C. H., Elema, J. D., Ramaekers, F., Poppema, S., Brouwer, M., van der Veen, A. Y., Mesander, G., and The, T. H. Characterization of three new variant type cell lines derived from small cell carcinoma of the lung. Cancer Res., 45: 6024-6033, 1985.
6. Berendsen, H. H., De Leij, L., de Vries, E. G., Mesander, G., Mulder, N. H., de Jong, B., Buys, C. H., Postmus, P. E., Poppema, S., and Sluiter, H. J. Characterization of three small cell lung cancer cell lines established from one patient during longitudinal follow-up. Cancer Res., 48: 6891-6899, 1988.
7. Bulte, J. W., Go, K. G., Zuiderveen, F., The, T. H., and De Leij, L. Intracerebral and subcutaneous xenografts of human SCLC in the nude rat: comparison of monoclonal antibody localization and tumor infiltrating lymphocytes. J. Neurooncol., 16: 11-18, 1993.
8. Pettengill, O. S., Sorenson, G. D., Wurster-Hill, D. H., Curphey, T. J., Noll, W. W., Cate, C. C., and Maurer, L. H. Isolation and growth characteristics of continuous cell lines from small-cell carcinoma of the lung. Cancer (Phila.), 45: 906-918, 1980.
9. Carney, D. N., Gazdar, A. F., Bepler, G., Guccion, J. G., Marangos, P. J., Moody, T. W., Zweig, M. H., and Minna, J. D. Establishment and identification of small cell lung cancer cell lines having classic and variant features. Cancer Res., 45: 2913-2923, 1985.
10. Bepler, G., Jaques, G., Neumann, K., Aumuller, G., Gropp, C., and Havemann, K. Establishment, growth properties, and morphological characteristics of permanent human small cell lung cancer cell lines. J. Cancer Res. Clin. Oncol., 113: 31-40, 1987.
11. Bepler, G., Jaques, G., Koehler, A., Gropp, C., and Havemann, K. Markers and characteristics of human SCLC cell lines. Neuroendocrine markers, classical tumor markers, and chromosomal characteristics of permanent human small cell lung cancer cell lines. J. Cancer Res. Clin. Oncol., 113: 253-259, 1987.
12. Eisen, M. B., Spellman, P. T., Brown, P. O., and Botstein, D. Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. USA, 95: 14863-14868, 1998.
13. Rygaard, K., Vindeløv, L. L., and Spang-Thomsen, M. Expression of myc family oncoproteins in small-cell lung-cancer cell lines and xenografts. Int. J. Cancer, 54: 144-152, 1993.
14. Kirkin, A. F., Dzhandzhugazyan, K N., and Zeuthen, J. Cancer/testis antigens: structural and immunobiological properties. Cancer Investig., 20: 222-236, 2002.
15. Anbazhagan, R., Tihan, T., Bomman, D. M., Johnston, J. C., Saltz, J. H., Weigering, A., Piantadosi, S., and Gabrielson, E. Classification of small cell lung cancer and pulmonary carcinoid by gene expression profiles. Cancer Res., 59: 5119-5122, 1999.
16. Zhang, L., Cilley, R. E., and Chinoy, M. R. Suppression subtractive hybridization to identify gene expressions in variant and classic small cell lung cancer cell lines. J. Surg. Res., 93: 108-119, 2000.
17. Brambilla, E., Travis, W. D., Colby, T. V., Corrin, B., and Shimosato, Y. The new World Health Organization classification of lung tumours. Eur. Respir. J., 18: 1059-1068, 2001.
18. Van den Eynde, B. J., and Boon, T. Tumor antigens recognized by T lymphocytes. Int. J. Clin. Lab. Res., 27: 81-86, 1997.
19. Wistuba, I. I., Gazdar, A. F., and Minna, J. D. Molecular genetics of small cell lung carcinoma. Semin. Oncol., 28: 3-13, 2001.
20. Helin, K., Holm, K., Niebuhr, A., Eiberg, H., Tommerup, N., Hougaard, S., Poulsen, H. S., Spang-Thomsen, M., and Nørgaard, P. Loss of the retinoblastoma protein-related p130 protein in small cell lung carcinoma. Proc. Natl. Acad. Sci. USA, 94: 6933-6938, 1997.
21. Takahashi, T., Takahashi, T., Suzuki, H., Hida, T., Sekido, Y., Ariyoshi, Y., and Ueda, R. The p53 gene is very frequently mutated in small-cell lung cancer with a distinct nucleotide substitution pattern. Oncogene, 6: 1775-1778, 1991.
22. Shimizu, E., Coxon, A., Otterson, G. A., Steinberg, S. M., Kratzke, R. A., Kim, Y. W., Fedorko, J., Oie, H., Johnson, B. E., and, Mulshine, J. L. RB protein status and clinical correlation from 171 cell lines representing lung cancer, extrapulmonary small cell carcinoma, and mesothelioma. Oncogene, 9: 2441-2448, 1994.
23. Chen, H., Biel, M. A., Borges, M. W., Thiagalingam, A., Nelkin, B. D., Baylin, S. B., and Ball, D. W. Tissue-specific expression of human achaete-scute homologue-1 in neuroendocrine tumors: transcriptional regulation by dual inhibitory regions. Cell Growth Differ., 8: 677-686, 1997.
24. Nakakura, E. K., Watkins, D. N., Schuebel, K. E., Sriuranpong, V., Borges, M. W., Nelkin, B. D., and Ball, D. W. Mammalian Scratch: a neural-specific Snail family transcriptional repressor. Proc. Natl. Acad. Sci. USA, 98: 4010-4015, 2001.
25. Kaufmann, O., Georgi, T., and Dietel, M. Utility of 123C3 monoclonal antibody against CD56 (NCAM) for the diagnosis of small cell carcinomas on paraffin sections. Hum. Pathol., 28: 1373-1378, 1997.
26. Kibbelaar, R. E., Moolenaar, K. E., Michalides, R. J., Van Bodegom, P. C., Vanderschueren, R. G., Wagenaar, S. S., Dingemans, K. P., Bitter-Suermann, D., Dalesio, O., van Zandwijk, N., and Mooi, W. J. Neural cell adhesion molecule expression, neuroendocrine differentiation and prognosis in lung carcinoma. Eur. J. Cancer, 27: 431-435, 1991.
27. Rygaard, K., Møller, C., Bock, E., and Spang-Thomsen, M. Expression of cadherin and NCAM in human small cell lung cancer cell lines and xenografts. Br. J. Cancer, 65: 573-577, 1992.
28. Hosono, M., Hosono, M. N., Kraeber-Bodere, F., Devys, A., Thedrez, P., Faivre-Chauvet, A., Gautherot, E., Barbet, J., and Chatal, J. F. Two-step targeting and dosimetry for small cell lung cancer xenograft with anti-NCAM/antihistamine bispecific antibody and radioiodinated bivalent hapten. J. Nucl. Med., 40: 1216-1221, 1999.
29. Hosono, M. N., Hosono, M., Mishra, A. K., Faivre-Chauvet, A., Gautherot, E., Barbet, J., Knapp, F. F., Jr., and Chatal, J. F. Rhenium-188-labeled anti-neural cell adhesion molecule antibodies with 2-iminothiolane modification for targeting small-cell lung cancer. Ann. Nucl. Med., 14: 173-179, 2000.
30. Kwa, H. B., Verhoeven, A. H., Storm, J., van Zandwijk, N., Mooi, W. J., and Hilkens, J. Radioimmunotherapy of small-cell lung cancer xenografts using 131I-labelled anti-NCAM monoclonal antibody 123C3. Cancer Immunol. Immunother., 41: 169-174, 1995.
31. Papanastassiou, V., Pizer, B. L., Coakham, H. B., Bullimore, J., Zananiri, T., and Kemshead, J. T. Treatment of recurrent and cystic malignant gliomas by a single intracavity injection of 131I monoclonal antibody: feasibility, pharmacokinetics and dosimetry. Br. J. Cancer, 67: 144-151, 1993.
32. Lynch, T. J., Jr., Lambert, J. M., Coral, F., Shefner, J., Wen, P., Blattler, W. A., Collinson, A. R., Ariniello, P. D., Braman, G., Cook, S., Esseltine, D., Elias, A., Skarin, A., and Ritz, J. Immunotoxin therapy of small-cell lung cancer: a phase I study of N901- blocked ricin. J. Clin. Oncol., 15: 723-734, 1997.
33. Roy, D. C., Ouellet, S., Le Houillier, C., Ariniello, P. D., Perreault, C., and Lambert, J. M. Elimination of neuroblastoma and small-cell lung cancer cells with an anti-neural cell adhesion molecule immunotoxin. J. Natl. Cancer Inst., 88: 1136-1145, 1996.
34. Yu, A., Choi, J., Ohno, K., Levin, B., Rom, W. N., and Meruelo, D. Specific cell targeting for delivery of toxins into small-cell lung cancer using a streptavidin fusion protein complex. DNA Cell Biol., 19: 383-388, 2000.
35. Zangemeister-Wittke, U., Collinson, A. R., Frosch, B., Waibel, R., Schenker, T., and Stahel, R. A. Immunotoxins recognising a new epitope on the neural cell adhesion molecule have potent cytotoxic effects against small cell lung cancer. Br. J. Cancer, 69: 32-39, 1994.
36. Rønn, L. C., Olsen, M., Ostergaard, S., Kiselyov, V., Berezin, V., Mortensen, M. T., Lerche, M. H., Jensen, P. H., Soroka, V., Saffell, J. L., Doherty, P., Poulsen, F. M., Bock, E., Holm, A., and Saffells, J. L. Identification of a neuritogenic ligand of the neural cell adhesion molecule using a combinatorial library of synthetic peptides. Nat. Biotechnol., 17: 1000-1005, 1999.
37. Bräuner-Osborne, H., Egebjerg, J., Nielsen, E. O., Madsen, U., and Krogsgaard-Larsen, P. Ligands for glutamate receptors: design and therapeutic prospects. J. Med. Chem., 43: 2609-2645, 2000.
38. Gasparini, F., Bruno, V., Battaglia, G., Lukic, S., Leonhardt, T., Inderbitzin, W., Laurie, D., Sommer, B., Varney, M. A., Hess, S. D., Johnson, E. C., Kuhn, R., Urwyler, S., Sauer, D., Portet, C., Schmutz, M., Nicoletti, F., and Flor, P. J. (R.S)-4-phosphonophenylglycine, a potent and selective group III metabotropic glutamate receptor agonist, is anticonvulsive and neuroprotective in vivo. J. Pharmacol. Exp. Ther., 289: 1678-1687, 1999.
39. Breslin, M. B., Zhu, M., Notkins, A. L., and Lan, M. S. Neuroendocrine differentiation factor. IA-1, is a transcriptional repressor and contains a specific DNA-binding domain: identification of consensus IA-1 binding sequence. Nucleic Acids Res., 30: 1038-1045, 2002.
40. Kirkpatrick, L. L., Matzuk, M. M., Dodds, D. C., and Perin, M. S. Biochemical interactions of the neuronal pentraxins. Neuronal pentraxin (NP) receptor binds to taipoxin and taipoxin-associated calcium-binding protein 49 via NP1 and NP2. J Biol. Chem., 275: 17786-17792, 2000.
41. Kim, D. H., Iijima, H., Goto, K., Sakai, J., Ishii, H., Kim, H. J., Suzuki, H., Kondo, H., Saeki, S., and Yamamoto, T. Human apolipoprotein E receptor 2. A novel lipoprotein receptor of the low density lipoprotein receptor family predominantly expressed in brain. J. Biol. Chem., 271: 8373-8380, 1996.
42. Argraves, W. S. Members of the low density lipoprotein receptor family control diverse physiological processes. Front. Biosci., 6: D406-D416, 2001.
43. Shaw, S. K., Cepek, K. L., Murphy, E. A., Russell, G. J., Brenner, M. B., and Parker, C. M. Molecular cloning of the human mucosal lymphocyte integrin α E subunit. Unusual structure and restricted RNA distribution. J. Biol. Chem., 269: 6016-6025, 1994.
44. Kilshaw, P. J. α E β 7. Mol. Pathol., 52: 203-207, 1999.
45. McCabe, C. J., and Gittoes, N. J. PTTG-a new pituitary tumour transforming gene. J. Endocrinol., 162: 163-166, 1999.
46. Kakar, S. S., and Jennes, L. Molecular cloning and characterization of the tumor transforming gene (TUTR1): a novel gene in human tumorigenesis. Cytogenet. Cell Genet., 84: 211-216, 1999.
47. Zou, H., McGarry, T. J., Bernal, T., and Kirschner, M. W. Identification of a vertebrate sister-chromatid separation inhibitor involved in transformation and tumorigenesis. Science (Wash. DC), 285: 418-422, 1999.
48. Ueno, K., Inoue, Y., Kawaguchi, T., Hosoe, S., and Kawahara, M. Increased serum levels of basic fibroblast growth factor in lung cancer patients: relevance to response of therapy and prognosis. Lung Cancer, 31: 213-219, 2001.
49. Little, C. D., Nau, M. M., Carney, D. N., Gazdar, A. F., and Minna, J. D. Amplification and expression of the c-myc oncogene in human lung cancer cell lines. Nature (Lond.), 306: 194-196, 1983.
50. Johnson, B. E., Russell, E., Simmons, A. M., Phelps, R., Steinberg, S. M., Ihde, D. C., and Gazdar, A. F. MYC family DNA amplification in 126 tumor cell lines from patients with small cell lung cancer. J. Cell. Biochem. Suppl., 24: 210-217, 1996.
51. Gazzeri, S., Brambilla, E., Jacrot, M., Chauvin, C., Benabid, A. L., and Brambilla, C. Activation of myc gene family in human lung carcinomas and during heterotransplantation into nude mice. Cancer Res., 51: 2566-2571, 1991.
52. De Plaen, E., Arden, K., Traversari, C., Gaforio, J. J., Szikora, J. P., De Smet, C., Brasseur, F., van der Bruggen P., Lethe, B., and Lurquin, C., Structure, chromosomal localization, and expression of 12 genes of the MAGE family. Immunogenetics, 40: 360-369, 1994.
53. Gillespie, A. M., and Coleman, R. E. The potential of melanoma antigen expression in cancer therapy. Cancer Treat. Rev., 25: 219-227, 1999.
54. Yoshimatsu, T., Yoshino, I., Ohgami, A., Takenoyama, M., Hanagiri, T., Nomoto, K., and Yasumoto, K. Expression of the melanoma antigen-encoding gene in human lung cancer. J. Surg. Oncol., 67: 126-129, 1998.
55. Bolon, I., Devouassoux, M., Robert, C., Moro, D., Brambilla, C., and Brambilla, E. Expression of urokinase-type plasminogen activator, stromelysin 1, stromelysin 3, and matrilysin genes in lung carcinomas. Am. J. Pathol., 150: 1619-1629, 1997.
56. Michael, M., Babic, B., Khokha, R., Tsao, M., Ho, J., Pintilie, M., Leco, K., Chamberlain, D., and Shepherd, F. A. Expression and prognostic significance of metalloproteinases and their tissue inhibitors in patients with small-cell lung cancer. J. Clin. Oncol., 17: 1802-1808, 1999.
57. Danø, K., Rømer, J., Nielsen, B. S., Bjørn, S., Pyke, C., Rygaard, J., and Lund, L. R. Cancer invasion and tissue remodeling-cooperation of protease systems and cell types. APMIS. 107: 120-127, 1999.
58. Narasaki, F., Matsuo, I., Ikuno, N., Fukuda, M., Soda, H., and Oka, M. Multidrug resistance-associated protein (MRP) gene expression in human lung cancer. Anticancer Res., 16: 2079-2082, 1996.
59. Gemma, A., Hosoya, Y., Seike, M., Uematsu, K., Kurimoto, F., Hibino, S., Yoshimura, A., Shibuya, M., Kudoh, S., and Emi, M. Genomic structure of the human MAD2 gene and mutation analysis in human lung and breast cancers. Lung Cancer, 32: 289-295, 2001.
60. Gazzeri, S., Della, V., V. Chaussade, L., Brambilla, C., Larsen, C. J., and Brambilla, E. The human p19ARF protein encoded by the β transcript of the p16INK4a gene is frequently lost in small cell lung cancer. Cancer Res., 58: 3926-3931, 1998.
61. Yuan, J., Knorr, J., Altmannsberger, M., Goeckenjan, G., Ahr, A., Scharl, A., and Strebhardt, K. Expression of p16 and lack of pRB in primary small cell lung cancer. J. Pathol., 189: 358-362, 1999.
62. Krarup, M., Poulsen, H. S., and Spang-Thomsen, M. Expression of cell cycle regulating factor mRNA in small cell lung cancer xenografts. Folia Microbiol. (Praha), 43: 501-503, 1998.
63. Modi, S., Kubo, A., Oie, H., Coxon, A. B., Rehmatulla, A., and Kaye, F. J. Protein expression of the RB-related gene family and SV40 large T antigen in mesothelioma and lung cancer. Oncogene, 19: 4632-4639, 2000.
64. Rygaard, K., Sørenson, G. D., Pettengill, O. S., Cate, C. C., and Spang-Thomsen, M. Abnormalities in structure and expression of the retinoblastoma gene in small cell lung cancer cell lines and xenografts in nude mice. Cancer Res., 50: 5312-5317, 1990.
65. Otterson, G. A., Kratzke, R. A., Coxon, A., Kim, Y. W., and Kaye, F. J. Absence of p16INK4 protein is restricted to the subset of lung cancer lines that retains wildtype RB. Oncogene, 9: 3375-3378, 1994.
66. Yarbrough, W. G., Bessho, M., Zanation, A., Bisi, J. E., and Xiong, Y. Human tumor suppressor ARF impedes S-phase progression independent of p53. Cancer Res., 62: 1171-1177, 2002.
67. Parisi, T., Pollice, A., Di Cristofano, A., Calabro, V., and La Mantia, G. Transcriptional regulation of the human tumor suppressor p14(ARF) by E2F1, E2F2, E2F3, and Sp1-like factors. Biochem. Biophys. Res. Commun., 291: 1138-1145, 2002.
68. Eymin, B., Gazzéri, S., Brambilla, C., and Brambilla, E. Distinct pattern of E2F1 expression in human lung tumours: E2F1 is upregulated in small cell lung carcinoma. Oncogene, 20: 1678-1687, 2001.
69. Nyati, M. K., Sreekumar, A., Li, S., Zhang, M., Rynkiewicz, S. D., Chinnaiyan, A. M., Rehemtulla, A., and Lawrence, T. S. High and selective expression of yeast cytosine deaminase under a carcinoembryonic antigen promoter-enhancer. Cancer Res., 62: 2337-2342, 2002.
70. Morimoto, E., Inase, N., Mlyake, S., and Yoshizawa, Y. Adenovirus-mediated suicide gene transfer to small cell lung carcinoma using a tumor-specific promoter. Anticancer Res., 21: 329-331, 2001.
71. Tanaka, M., Inase, N., Miyake, S., and Yoshizawa, Y. Neuron specific enolase promoter for suicide gene therapy in small cell lung carcinoma. Anticancer Res., 21: 291-294, 2001.
72. Li, Q., Notkins, A. L., and Lan, M. S. Molecular characterization of the promoter region of a neuroendocrine tumor marker. IA-1. Biochem. Biophys. Res. Commun., 236: 776-781, 1997.
73. Nomura, N., Nagase, T., Miyajima, N., Sazuka, T., Tanaka, A., Sato, S., Seki, N., Kawarabayasi, Y., Ishikawa, K., and Tabata, S. Prediction of the coding sequences of unidentified human genes. II. The coding sequences of 40 new genes (KIAA0041-KIAA0080) deduced by analysis of cDNA clones from human cell line KG-1. DNA Res., 1: 223-229, 1994.
74. Nagase, T., Miyajima, N., Tanaka, A., Sazuka, T., Seki, N., Sato, S., Tabata, S., Ishikawa, K., Kawarabayasi, Y., and, Kotani, H. Prediction of the coding sequences of unidentified human genes. III. The coding sequences of 40 new genes (KIAA0081-KIAA0120) deduced by analysis of cDNA clones from human cell line KG-1. DNA Res., 2: 37-43, 1995.